Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development

Journal of Hepatology

Volumn 51, Issue 4, 2009, Pages 682-689

  Zocco, Maria Assunta ^a   Di Stasio, Enrico ^b   De Cristofaro, Raimondo ^a   Novi, Marialuisa ^a   Ainora, Maria Elena ^a   Ponziani, Francesca ^a   Riccardi, Laura ^a   Lancellotti, Stefano ^a   Santoliquido, Angelo ^a   Flore, Roberto ^a   Pompili, Maurizio ^a   Rapaccini, Gian Lodovico ^a   Tondi, Paolo ^a   Gasbarrini, Giovanni Battista ^a   Landolfi, Raffaele ^a   Gasbarrini, Antonio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Liver cirrhosis; MELD score; Portal flow velocity; Portal vein thrombosis; Thrombotic risk factors

Indexed keywords

ANTITHROMBIN; D DIMER; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MODEL; PORTAL VEIN BLOOD FLOW; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; THROMBOGENESIS; VASCULAR PATENCY;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBINS; BLOOD FLOW VELOCITY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; PROGNOSIS; PROTEIN C; PROTEIN S; RISK FACTORS; VENOUS THROMBOSIS;

EID: 69949162791     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.03.013     Document Type: Article

References (49)

1. O'Grady J.G., Langley P.G., Isola L.M., Aledort L.M., and Williams R. Coagulopathy of fulminant hepatic failure. Semin Liver Dis 6 (1986) 159-163
2. Mammen E.F. Coagulation abnormalities in liver disease. Haemotol Oncol Clin North Am 6 (1992) 1247-1257
3. Tripodi A., Salerno F., Chantarangkul V., Clerici M., Cazzaniga M., Primignani M., et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 41 (2005) 553-558
4. Kelly D.A., and Summerfield J.A. Hemostasis in liver disease. Semin Liver Dis 7 (1987) 182-191
5. Mammen E.F. Coagulation defects in liver disease. Med Clin North Am 78 (1994) 545-554
6. Al Ghumlas A.K., Abdel Gader A.G., and Al Faleh F.Z. Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests?. Blood Coagul Fibrinolysis 16 (2005) 329-335
7. Carrr J.M. Disseminated intravascular coagulation in cirrhosis. Hepatology 10 (1989) 103-110
8. Wanless I.R., Wong F., Blendis L.M., Greig P., Heathcote E.J., and Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 21 (1995) 1238-1247
9. Wanless I.R., Liu J.J., and Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 21 (1995) 1232-1237
10. Papatheodoridis G.V., Papakonstantinou E., Andrioti E., Cholangitas E., Petraki K., Kontopoulou I., et al. Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 52 (2003) 404-409
11. Assy N., Bekirov I., Mejritsky Y., Solomon L., Szvalb S., and Hussein O. Association between thrombotic risk factors and extent of fibrosis in patients with non alcoholic fatty liver diseases. World J Gastroenterol 11 (2005) 5834-5839
12. He X.F., Wen Z.B., Liu M.J., Zhang H., Li Q., and He S.L. Levels of plasma des-gamma-carboxy protein C and prothrombin in patients with liver diseases. World J Gastroenterol 10 (2004) 3073-3075
13. Vukovich T.H., Teufelsbauer H., Fritzer M., Kreuzer S., and Knoflach P. Hemostasis activation in patients with liver cirrhosis. Thromb Res 77 (1995) 271-278
14. Webster G.J.M., Burroughs A.K., and Riordan S.M. Review article: portal vein thrombosis-new insight into aetiology and management. Aliment Pharmacol Ther 21 (2005) 1-9
15. Okuda K., Ohnishi K., Kimura K., Matsutani S., Sumida M., Goto N., et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 89 (1985) 279-286
16. Amitrano L., Guardascione M.A., Brancaccio V., Margaglione M., Manguso F., Iannaccone L., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 40 (2004) 736-741
17. Belli L., Romani F., Sansalone C.V., Aseni P., and Rondinara G. Portal thrombosis in cirrhotics. A retrospective analysis. Ann Surg 203 (1986) 286-291
18. Francoz C., Belghiti J., Vilgrain V., Sommacale D., Paradis V., Condat B., et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 54 (2005) 691-697
19. Webster G.J.M., Burroughs A.K., and Riordan S.M. Review article: portal vein thrombosis-new insight into aetiology and management. Aliment Pharmacol Ther 21 (2005) 1-9
20. Nonami T., Yokoyama I., Iwatsuki S., and Starzl T.E. The incidence of portal vein thrombosis at liver transplantation. Hepatology 16 (1992) 1195-1198
21. Yerdel M.A., Gunson B., Mirza D., Karayalçin K., Olliff S., Buckels J., et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69 (2000) 1873-1881
22. Politoske D., Ralls P., and Korula J. Portal vein thrombosis following endoscopic variceal sclerotherapy. Prospective controlled comparison in patients with cirrhosis. Dig Dis Sci 41 (1996) 185-190
23. Mangia A., Villani M.R., Cappucci G., Santoro R., Ricciardi R., Facciorusso D., et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and biologic factors. Eur J Gastroenterol Hepatol 17 (2005) 745-751
24. Kawasaki S., Henderson J.M., Riepe S.P., Brooks W.S., and Hertzler G. Endoscopic variceal sclerosis does not increase the risk of portal venous thrombosis. Gastroenterology 102 (1992) 206-215
25. Amitrano L., Brancaccio V., Guardascione M.A., Margaglione M., Sacco M., Martino R., et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 34 (2002) 535-538
26. Yonemitsu Y., Yanaga K., Matsumata T., and Sugimachi K. Portal vein thrombosis due to antithrombin III deficiency. A case report. Angiology 46 (1995) 1043-1047
27. Violi F., Ferro D., Basili S., D'Angelo A., Mazzola G., Quintarelli C., et al. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. Br Med J 309 (1994) 239-240
28. Prieto J., Yuste J.R., Beloqui O., Civeira M.P., Riezu J.I., Aguirre B., et al. Anticardiolipin antibodies in chronic hepatitis C: implications of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 23 (1996) 199-204
29. Mangia A., Margaglione M., Cascavilla I., Gentile R., Cappucci G., Facciorusso D., et al. Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol 94 (1999) 2983-2987
30. Amitrano L., Brancaccio V., Guardascione M.A., Margaglione M., Iannacone L., D'Andrea G., et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 31 (2000) 345-348
31. Majluf-Cruz A., Hurtado-Monroy R., Sansores Garcia L., and Labardini-Mendez J. The incidence of protein C deficiency in thrombosis-related portal hypertension. Am J Gastroenterol 91 (1996) 976-980
32. Romero Gomez R., Suarez Garzia E., Lopez Lacomba D., Grande L., Marchsnte I., and Castro Fernandez M. Antiphopholipids antibodies: relationship to portal vein thrombosis in cirrhotic liver patients. J Clin Gastroenterol 31 (2000) 237-240
33. Erkan O., Bozdayi A.M., Disibeyaz S., Oguz D., Ozcan M., Bahar K., et al. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol 17 (2005) 339-343
34. Amitrano L., Guardascione M.A., Ames P.R., Margaglione M., Iannaccone L., Brancaccio V., et al. Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation. Thromb Haemost 95 (2006) 221-223
35. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., et al. A model for end-stage liver disease. Hepatology 33 (2001) 464-470
36. Huemer R.P., and Lee K.D. Automated Lowry method for microgram protein determination. Analyt Biochem 37 (1970) 149-153
37. Sabbà C., Merkel C., Zoli M., Ferraioli G., Gaiani S., Sacerdoti D., et al. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of cooperative training program. Hepatology 21 (1995) 428-433
38. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
39. Bosch J., and Reverter J.C. The coagulopathy of cirrhosis: myth or reality?. Hepatology 41 (2005) 434-435
40. De Caterina M., Tarantino G., Farina C., Arena A., di Maro G., Esposito P., et al. Haemostasis unbalance in Pugh-scored liver cirrhosis: characteristic changes of plasma levels of protein C versus protein S. Haemostasis 23 (1993) 229-235
41. Raya-Sanchez J.M., Gonzales-Reimers E., Rodriguez-Martin J.M., Santolaria- Fernandez F., Molina-Perez M., Rodriguez-Moreno F., et al. Coagulation inhibitors in alcoholic liver cirrhosis. Alcohol 15 (1998) 19-23
42. Janssen H.L., Wijnhoud A., Haagsma E.B., van Uum S.H., van Nieuwkerk C.M., Adang R.P., et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 49 (2001) 720-724
43. Gayowski T.J., Marino I.R., Doyle H.R., Echeverri L., Mieles L., Todo S., et al. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res 60 (1996) 333-338
44. Sobhonslidsuk A., and Reddy K.R. Portal vein thrombosis: a concise review. Am J Gastroenterol. 97 (2002) 535-541
45. Tripodi A., Chantarangkul V., Martinelli I., Bucciarelli P., and Mannucci P.M. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 104 (2004) 3631-3634
46. Manzanet G., Sanjuán F., Orbis P., López R., Moya A., Juan M., et al. Liver transplantation in patients with portal vein thrombosis. Liver Transpl 7 (2001) 125-131
47. Gaiani S., Bolondi L., Li Bassi S., Zironi G., Siringo S., and Barbara L. Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology 100 (1991) 160-167
48. Zironi G., Gaiani S., Fenyves D., Rigamonti A., Bolondi L., and Barbara L. Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol 16 (1992) 298-303
49. Zoli M., Iervese T., Merkel C., Bianchi G., Magalotti D., Marchesini G., et al. Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. J Hepatol 17 (1993) 56-61